Dynamic42 GmbH is company highly specialized in the controlled, standardized and scalable production and development of human Organ-on-Chip technology. Our biochip-based microphysiological platform can be used to screen new pharmaceutical compounds, chemicals and nutritional supplements as well as it is possible to set up specific disease models to test new therapy options. Our well characterized organ models show typical cell type-specific morphology, marker expression, certain physiologic functions and are highly scalable in cell type complexity. Here, Dynamic42 is specialized in integrating components of the immune system like tissue-resident macrophages or circulating immune cells into organ-on-chip technology. Dynamic42 Organ-on-Chip technology contributes to obtain scientific data closer related to human physiology and can be used in a variety of scientific and pharmaceutic research fields.
Location: Germany, Thuringia, Jena
Employees: 1-10
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | bm-t betei... | bm-t.de |
Mentions in press and media 4
| Date | Title | Description |
| 18.06.2023 | Jena-based biotechnology company “Dynamic42” raises mid-seven-figure investment in Series A financing round | Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round. The company, which was spun off from the “Center of Sepsis Control and Care” of the University Hospital Jena in March 2018, was... |
| 13.06.2023 | Fernride sammelt 31 Millionen ein – Caya bekommt 6 Millionen – Flixcheck erhält 1 Million | Im #DealMonitor für den 13. Juni werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Arc... |
| - | Dynamic42 GmbH Raises First Seed Round | Dynamic42 GmbH has successfully completed a six-figure fundraising in early summer 2019 as an important step towards future growth. The new investment round will enable Dynamic42 to further its product development and market ex... |
| - | The Jena-based biotech company «Dynamic42» raised a seven-digit investment | Dynamic42 GmbH has concluded a seven-digit start-up financing round. The company, which spun off from the «Center of Sepsis Control and Care» (CSCC) of the University Hospital Jena in March 2018, was able to convince the investor... |